Spectinomycin: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) |
||
| Line 13: | Line 13: | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
'''[[Spectinomycin description|Description]]''' | ''' [[Spectinomycin description|Description]]''' | ||
'''| [[Spectinomycin clinical pharmacology|Clinical Pharmacology]]''' | '''| [[Spectinomycin clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[Spectinomycin microbiology|Microbiology]]''' | '''| [[Spectinomycin microbiology|Microbiology]]''' | ||
Revision as of 00:50, 31 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Spectinomycin is an aminocyclitol antibiotic produced by the bacterium Streptomyces spectabilis.
Category
Aminocyclitol
US Brand Names
TROBICIN®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Dosage and Administration | How Supplied
Mechanisms of Action
It binds to the 30S ribosomal subunit in invading bacteria and interrupts protein synthesis.